Study highlights effectiveness of vaccine against Ebola

Authored by News Desk

As the latest in a series of studies, researchers at Plymouth University, National Institutes of Health and University of California, Riverside, have shown the ability of a vaccine vector based on a common herpesvirus called cytomegalovirus (CMV) expressing Ebola virus glycoprotein (GP), to provide protection against Ebola virus in the experimental rhesus macaque, non-human primate (NHP) model...

Plymouth's role in Sierra Leone Ebola-free status

Authored by Mary

Sierra Leone officially declared Ebola-free – partly thanks to a team of medical education researchers and virtual learning technicians from Plymouth.

The team, made up of clinicians, academics and programmers from Plymouth University Peninsula Schools of Medicine and Dentistry (PUPSMD) and Plymouth Hospitals NHS Trust, has worked with Masanga Hospital in Sierra Leone and the Masanga...

Could self-disseminating vaccines cut off emerging infectious diseases at source?

Authored by Mary

An expert review identifies state-of-the-art of self-disseminating vaccines as a new and potentially powerful strategy to circumvent such diseases at the animal source before their establishment as the next human pandemic

The 2014/2015 Ebola outbreak in West Africa shone the spotlight not only on the unpreparedness of local health services and science to deal with the pandemic, but...

Plymouth scientist shares experience of helping in fight against Ebola

Authored by News Desk

A Biomedical Scientist from Plymouth Hospitals NHS Trust has recently returned from Sierra Leone after helping with the fight against Ebola.

Katina Kraemer, who is based in the Microbiology Laboratory at Derriford Hospital, answered the call for volunteers to work in West Africa in December. Out in Sierra Leone for Christmas, Katina left on December 21st and returned back to the UK at...